# Diplotype analysis of NUDT15 variants and 6-mercaptopurine sensitivity in pediatric lymphoid neoplasms

## Metadata
**Authors:** Shinichi Tsujimoto, Tomoo Osumi, Meri Uchiyama, Ryota Shirai, Takaya Moriyama, Rina Nishii, Yuji Yamada, Ko Kudo, Masahiro Sekiguchi, Yuki Arakawa, Masanori Yoshida, Toru Uchiyama, Kiminori Terui, Shuichi Ito, Katsuyoshi Koh, Junko Takita, Etsuro Ito, Daisuke Tomizawa, Atsushi Manabe, Nobutaka Kiyokawa, Jun J Yang, Motohiro Kato
**Journal:** Leukemia
**Date:** 2018 Jul 2
**DOI:** [10.1038/s41375-018-0190-1](https://doi.org/10.1038/s41375-018-0190-1)
**PMID:** 29967377
**PMCID:** PMC6289816
**URL:** https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289816/
**PDF:** [https://pmc.ncbi.nlm.nih.gov/articles/PMC6289816/pdf/nihms-991249.pdf](https://pmc.ncbi.nlm.nih.gov/articles/PMC6289816/pdf/nihms-991249.pdf)

## Supplementary Material

## Acknowledgements

The authors would like to thank Ms. Natsuko Ariizumi, Ms. Shinobu Kobayashi, and Ms. Yoshie Fukumasa for their technical assistance. We also thank Mr. Yukinori Yatsuda (Bio-rad) for his assistance with the ddPCR analysis. The authors thank Mr. James R. Valera of the Department of Education for Clinical Research of the National Center for Child Health and Development for his assistance in proofreading and editing this manuscript.

This study was supported in part by the Japan Society for the Promotion of Science (JSPS) through a Grant-in-Aid for Scientific Research (KAKENHI, grant number 17H04234), by a grant from the National Center for Child Health and Development (grant numbers 28–5), by grant 17km0405107h0005, 17ck0106253h0001, and 17ck0106219h0002 from the Japan Agency for Medical Research and development, (AMED), and by foundation for National Institutes of Health (GM118578). T.M is supported by the Garwood Fellowship at St. Jude Children’s Research Hospital.

## Associated Data

*This section collects any data citations, data availability statements, or supplementary materials included in this article.*

### Supplementary Materials

### Supplementary Materials

## References

1. Kato M, Ishimaru S, Seki M, Yoshida K, Shiraishi Y, Chiba K et al. Long-term outcome of 6-month maintenance chemotherapy for acute lymphoblastic leukemia in children. Leukemia 2017; 31: 580–584.  [DOI](https://doi.org/10.1038/leu.2016.274) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/27698447/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Leukemia&title=Long-term%20outcome%20of%206-month%20maintenance%20chemotherapy%20for%20acute%20lymphoblastic%20leukemia%20in%20children&author=M%20Kato&author=S%20Ishimaru&author=M%20Seki&author=K%20Yoshida&author=Y%20Shiraishi&volume=31&publication_year=2017&pages=580-584&pmid=27698447&doi=10.1038/leu.2016.274&)

2. Nielsen SN, Grell K, Nersting J, Abrahamsson J, Lund B, Kanerva J et al. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial. Lancet Oncol 2017; 18: 515–524.  [DOI](https://doi.org/10.1016/S1470-2045(17)30154-7) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/28258828/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&title=DNA-thioguanine%20nucleotide%20concentration%20and%20relapse-free%20survival%20during%20maintenance%20therapy%20of%20childhood%20acute%20lymphoblastic%20leukaemia%20(NOPHO%20ALL2008):%20a%20prospective%20substudy%20of%20a%20phase%203%20trial&author=SN%20Nielsen&author=K%20Grell&author=J%20Nersting&author=J%20Abrahamsson&author=B%20Lund&volume=18&publication_year=2017&pages=515-524&pmid=28258828&doi=10.1016/S1470-2045(17)30154-7&)

3. Kato M & Manabe A Treatment and biology of pediatric acute lymphoblastic leukemia. Pediatrics international : official journal of the Japan Pediatric Society 2018; 60: 4–12.  [DOI](https://doi.org/10.1111/ped.13457) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/29143423/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Pediatrics%20international%20:%20official%20journal%20of%20the%20Japan%20Pediatric%20Society&title=Treatment%20and%20biology%20of%20pediatric%20acute%20lymphoblastic%20leukemia&author=M%20Kato&author=A%20Manabe&volume=60&publication_year=2018&pages=4-12&pmid=29143423&doi=10.1111/ped.13457&)

4. Moriyama T, Nishii R, Perez-Andreu V, Yang W, Klussmann FA, Zhao X et al. NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity. Nat Genet 2016; 48: 367–373.  [DOI](https://doi.org/10.1038/ng.3508) | [PMC free article](/articles/PMC5029084/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/26878724/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nat%20Genet&title=NUDT15%20polymorphisms%20alter%20thiopurine%20metabolism%20and%20hematopoietic%20toxicity&author=T%20Moriyama&author=R%20Nishii&author=V%20Perez-Andreu&author=W%20Yang&author=FA%20Klussmann&volume=48&publication_year=2016&pages=367-373&pmid=26878724&doi=10.1038/ng.3508&)

5. Zgheib NK, Akika R, Mahfouz R, Aridi CA, Ghanem KM, Saab R et al. NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children’s Cancer Center of Lebanon. Pediatr Blood Cancer 2017; 64: 146–150.  [DOI](https://doi.org/10.1002/pbc.26189) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/27577869/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Pediatr%20Blood%20Cancer&title=NUDT15%20and%20TPMT%20genetic%20polymorphisms%20are%20related%20to%206-mercaptopurine%20intolerance%20in%20children%20treated%20for%20acute%20lymphoblastic%20leukemia%20at%20the%20Children%E2%80%99s%20Cancer%20Center%20of%20Lebanon&author=NK%20Zgheib&author=R%20Akika&author=R%20Mahfouz&author=CA%20Aridi&author=KM%20Ghanem&volume=64&publication_year=2017&pages=146-150&pmid=27577869&doi=10.1002/pbc.26189&)

6. Soler AM, Olano N, Mendez Y, Lopes A, Silveira A, Dabezies A et al. TPMT and NUDT15 genes are both related to mercaptopurine intolerance in acute lymphoblastic leukaemia patients from Uruguay. Br J Haematol 2017.  [DOI](https://doi.org/10.1111/bjh.14532) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/28146264/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Br%20J%20Haematol&title=TPMT%20and%20NUDT15%20genes%20are%20both%20related%20to%20mercaptopurine%20intolerance%20in%20acute%20lymphoblastic%20leukaemia%20patients%20from%20Uruguay&author=AM%20Soler&author=N%20Olano&author=Y%20Mendez&author=A%20Lopes&author=A%20Silveira&publication_year=2017&pmid=28146264&doi=10.1111/bjh.14532&)

7. Yang JJ, Landier W, Yang W, Liu C, Hageman L, Cheng C et al. Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia. J Clin Oncol 2015; 33: 1235–1242.  [DOI](https://doi.org/10.1200/JCO.2014.59.4671) | [PMC free article](/articles/PMC4375304/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/25624441/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&title=Inherited%20NUDT15%20variant%20is%20a%20genetic%20determinant%20of%20mercaptopurine%20intolerance%20in%20children%20with%20acute%20lymphoblastic%20leukemia&author=JJ%20Yang&author=W%20Landier&author=W%20Yang&author=C%20Liu&author=L%20Hageman&volume=33&publication_year=2015&pages=1235-1242&pmid=25624441&doi=10.1200/JCO.2014.59.4671&)

8. Tanaka Y, Kato M, Hasegawa D, Urayama KY, Nakadate H, Kondoh K et al. Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia. Br J Haematol 2015; 171: 109–115.  [DOI](https://doi.org/10.1111/bjh.13518) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/26033531/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Br%20J%20Haematol&title=Susceptibility%20to%206-MP%20toxicity%20conferred%20by%20a%20NUDT15%20variant%20in%20Japanese%20children%20with%20acute%20lymphoblastic%20leukaemia&author=Y%20Tanaka&author=M%20Kato&author=D%20Hasegawa&author=KY%20Urayama&author=H%20Nakadate&volume=171&publication_year=2015&pages=109-115&pmid=26033531&doi=10.1111/bjh.13518&)

9. Yang SK, Hong M, Baek J, Choi H, Zhao W, Jung Y et al. A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia. Nat Genet 2014; 46: 1017–1020.  [DOI](https://doi.org/10.1038/ng.3060) | [PMC free article](/articles/PMC4999337/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/25108385/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nat%20Genet&title=A%20common%20missense%20variant%20in%20NUDT15%20confers%20susceptibility%20to%20thiopurine-induced%20leukopenia&author=SK%20Yang&author=M%20Hong&author=J%20Baek&author=H%20Choi&author=W%20Zhao&volume=46&publication_year=2014&pages=1017-1020&pmid=25108385&doi=10.1038/ng.3060&)

10. Moriyama T, Nishii R, Lin TN, Kihira K, Toyoda H, Jacob N et al. The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia. Pharmacogenet Genomics 2017; 27: 236–239.  [DOI](https://doi.org/10.1097/FPC.0000000000000282) | [PMC free article](/articles/PMC5510236/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/28445187/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Pharmacogenet%20Genomics&title=The%20effects%20of%20inherited%20NUDT15%20polymorphisms%20on%20thiopurine%20active%20metabolites%20in%20Japanese%20children%20with%20acute%20lymphoblastic%20leukemia&author=T%20Moriyama&author=R%20Nishii&author=TN%20Lin&author=K%20Kihira&author=H%20Toyoda&volume=27&publication_year=2017&pages=236-239&pmid=28445187&doi=10.1097/FPC.0000000000000282&)

11. Moriyama T, Yang YL, Nishii R, Ariffin H, Liu C, Lin TN et al. Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry. Blood 2017; 130: 1209–1212.  [DOI](https://doi.org/10.1182/blood-2017-05-782383) | [PMC free article](/articles/PMC5606007/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/28659275/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Blood&title=Novel%20variants%20in%20NUDT15%20and%20thiopurine%20intolerance%20in%20children%20with%20acute%20lymphoblastic%20leukemia%20from%20diverse%20ancestry&author=T%20Moriyama&author=YL%20Yang&author=R%20Nishii&author=H%20Ariffin&author=C%20Liu&volume=130&publication_year=2017&pages=1209-1212&pmid=28659275&doi=10.1182/blood-2017-05-782383&)

12. Liang DC, Yang CP, Liu HC, Jaing TH, Chen SH, Hung IJ et al. NUDT15 gene polymorphism related to mercaptopurine intolerance in Taiwan Chinese children with acute lymphoblastic leukemia. Pharmacogenomics J 2016; 16: 536–539.  [DOI](https://doi.org/10.1038/tpj.2015.75) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/26503813/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Pharmacogenomics%20J&title=NUDT15%20gene%20polymorphism%20related%20to%20mercaptopurine%20intolerance%20in%20Taiwan%20Chinese%20children%20with%20acute%20lymphoblastic%20leukemia&author=DC%20Liang&author=CP%20Yang&author=HC%20Liu&author=TH%20Jaing&author=SH%20Chen&volume=16&publication_year=2016&pages=536-539&pmid=26503813&doi=10.1038/tpj.2015.75&)

13. Regan JF, Kamitaki N, Legler T, Cooper S, Klitgord N, Karlin-Neumann G et al. A rapid molecular approach for chromosomal phasing. PloS one 2015; 10: e0118270.  [DOI](https://doi.org/10.1371/journal.pone.0118270) | [PMC free article](/articles/PMC4349636/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/25739099/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=PloS%20one&title=A%20rapid%20molecular%20approach%20for%20chromosomal%20phasing&author=JF%20Regan&author=N%20Kamitaki&author=T%20Legler&author=S%20Cooper&author=N%20Klitgord&volume=10&publication_year=2015&pages=e0118270&pmid=25739099&doi=10.1371/journal.pone.0118270&)

14. Hidaka N, Iwama E, Kubo N, Harada T, Miyawaki K, Tanaka K et al. Most T790M mutations are present on the same EGFR allele as activating mutations in patients with non-small cell lung cancer. Lung Cancer 2017; 108: 75–82.  [DOI](https://doi.org/10.1016/j.lungcan.2017.02.019) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/28625653/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Lung%20Cancer&title=Most%20T790M%20mutations%20are%20present%20on%20the%20same%20EGFR%20allele%20as%20activating%20mutations%20in%20patients%20with%20non-small%20cell%20lung%20cancer&author=N%20Hidaka&author=E%20Iwama&author=N%20Kubo&author=T%20Harada&author=K%20Miyawaki&volume=108&publication_year=2017&pages=75-82&pmid=28625653&doi=10.1016/j.lungcan.2017.02.019&)

15. Chao K, Wang X, Cao Q, Qian J, Wu K, Zhu X et al. Combined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Analysis. Inflamm Bowel Dis 2017; 23: 1592–1599.  [DOI](https://doi.org/10.1097/MIB.0000000000001148) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/28570428/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Inflamm%20Bowel%20Dis&title=Combined%20Detection%20of%20NUDT15%20Variants%20Could%20Highly%20Predict%20Thiopurine-induced%20Leukopenia%20in%20Chinese%20Patients%20with%20Inflammatory%20Bowel%20Disease:%20A%20Multicenter%20Analysis&author=K%20Chao&author=X%20Wang&author=Q%20Cao&author=J%20Qian&author=K%20Wu&volume=23&publication_year=2017&pages=1592-1599&pmid=28570428&doi=10.1097/MIB.0000000000001148&)
